"The New York Blood Center Enterprises operates the world's oldest public cord blood bank, and the Chan Zuckerberg Biohub is a biomedical research network funded by Mark Zuckerberg and Priscilla Chan."
"Most of the umbilical cord blood collected at birth is discarded, along with the stem cells it contains, which are immunologically naive and capable of being reprogrammed into virtually any cell type."
"The collaboration represents an attempt to solve a structural problem that has constrained the field of cell therapy: the gap between the biology that researchers can create in a laboratory and the biology that can be manufactured, stored, and delivered to patients at scale."
The New York Blood Center Enterprises and the Chan Zuckerberg Biohub are collaborating to derive induced pluripotent stem cell lines from over 30,000 units of cord blood. Most umbilical cord blood is discarded, but it contains valuable stem cells. The collaboration seeks to create a library of immune-compatible stem cell lines for research in regenerative medicine, disease modeling, and cell therapy. This initiative addresses a significant challenge in cell therapy: bridging the gap between laboratory biology and scalable treatments for patients.
#induced-pluripotent-stem-cells #cord-blood #regenerative-medicine #cell-therapy #biomedical-research
Read at TNW | Health-Tech
Unable to calculate read time
Collection
[
|
...
]